Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. - Wikidata - wikimedia - TriplyDB

Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.

Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.

http://www.wikidata.org/entity/Q33203569

about

Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.Bone marrow cell recruitment mediated by inducible nitric oxide synthase/stromal cell-derived factor-1alpha signaling repairs the acoustically damaged cochlear blood-labyrinth barrier.Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.Do anesthetics and sampling strategies affect transcription analysis of fish tissues?Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas.Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression Clinical biomarkers for hypoxia targeting Myricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo.High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD Consortium Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types.Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis.A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells.Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer.Oxygen-mediated endocytosis in cancer.The tumor microenvironment in non-small-cell lung cancer New biomarkers for lung cancer.Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors.Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors.Hypoxia inducible factor-1 alpha plays a pivotal role in hepatic metastasis of pancreatic cancer: an immunohistochemical study.Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non-small cell lung cancer.Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1α induction.Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells.Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer.[Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer.Cyclophilin A expression and its prognostic significance in lung adenocarcinoma.

P2860

Q24794295-36DE40C3-6298-40DA-ABFC-C5A0E4AE8E6A Q26767514-394F7BB6-5E07-4232-8A42-EF626809AF6F Q29615944-D507E919-8A7F-4960-BBEC-3990560E0DE3 Q30249160-50B8BBB4-53B8-45E9-AE4E-5238D9EB2860 Q30472457-260BCE12-59B2-475D-BA34-4AC22425453F Q33206782-7DEA8F11-325A-4E07-8535-5EEB4FE0C292 Q33287226-74EE0018-BAAF-48B9-98C5-CB1AFBA6D0B4 Q33385608-4E7A83A1-2C34-4D2D-9E11-146522111438 Q33390467-5008F3D2-4CF8-4E5C-B2AF-2DA6D0F75F2F Q33588186-9707A126-001C-4607-844D-36003EEBA1CE Q33714638-D4862D4A-883B-4215-B100-2CF7F66D165E Q33829163-9140A00F-A258-47C6-A701-D5F4768629AF Q33903731-A08B83C9-3A1C-42B6-B68C-3AE503432FF6 Q34198666-08B03CAD-E801-4B63-AF32-B561E2998573 Q34199098-5E89AC12-D3E8-4C31-8047-334F91A8AFF6 Q34371559-2A66F039-429A-4469-8182-C24C96EA2B08 Q35059923-C592F985-C259-483C-8B09-619A37706A35 Q35103188-66317769-5834-4DC0-9B42-5A1B4D347FB4 Q35688354-3C9543F9-CDAE-499E-A57F-645399ED2202 Q35770249-E5B37ECA-A542-4F6D-93A4-91AD8590E7DD Q35841917-BE9F6C37-5E72-4E7E-837B-F00824B5DBEC Q36311791-313F59C5-C205-4345-A7CB-9E11271CEC41 Q36389325-CDB69A60-6BEE-472B-BE08-C4B70CE18465 Q36465299-CA69F7C6-EE0B-4226-A338-DBBC520B15AE Q37296289-21570EF0-2AA4-43E4-AF64-0EECCB7F07B7 Q37777872-7AECE5AC-29A0-4217-A92B-8A1B68BE1273 Q38089079-86B5F6CF-4F1A-4574-A3DF-FBB76982ABA0 Q38177264-67B29103-C897-40B3-901B-ED54508083E9 Q38821162-B7C4BA46-E121-4140-BAC3-684D8019E217 Q38836322-6D2DD4F5-8ECF-4507-916A-BDF403C1541F Q39051622-746F4786-CA84-4A3E-B2E0-A3A70E9E6C7A Q39396957-5A0DA2BB-98C5-4833-8262-8990A367E3D4 Q39478026-9178765A-4AEB-47DA-995E-00EDD2050DE4 Q39543717-B442C2E7-9D03-4FB5-A3D2-BB08C9B6F283 Q39739616-27AACCC7-E584-4055-AB1C-E086F98A5E0C Q39850353-6FCFEF7E-CB16-44EA-A3B0-FF99EB9196FB Q41454877-E0B4F7E0-B607-4F85-A48C-3263C7FDFF02 Q44600102-0C863E9F-E61A-46A2-8B4D-B7F10A9F131D Q45886897-AE7D9B63-D511-47DD-98D7-FBB10192647F Q50062587-EFDEEEA2-F104-4490-84CC-8D8B3DBC1273

P2860

Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.

http://www.wikidata.org/entity/Q33203569

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.

@ast

Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.

@en

type

label

Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.

@ast

Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.

@en

prefLabel

Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.

@ast

Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.

@en

P1433

Q33203569-E4C7A578-A07E-45D9-AA87-B364DE42EF57

P1476

Q33203569-D938262F-E52F-4A85-AD54-B1997B4F0F8C

P2093

Q33203569-063360F7-2D72-4D10-8513-0193D58B393B

Q33203569-4A579FCD-F216-4BFF-BDC2-ADCE39C3D266

Q33203569-5D19B5DC-B437-4CCA-BC11-379F504BD112

Q33203569-6D54AE8E-11A0-4CE1-AA88-2A15AE18D2A8

Q33203569-C748B2EE-237E-456A-A6EA-AAF1A7BC65B4

P2860

Q33203569-6E792753-352B-4D05-A6AA-490933994CD0

Q33203569-89D51CCC-612F-4DA9-AC88-63355493A229

Q33203569-984D3CB7-B764-4F0D-8A9F-A92078E9AD04

P304

Q33203569-7EBFB7C6-6D76-42C9-BE77-827DED8D531C

P31

Q33203569-75FE3391-B14C-4A26-85D3-26A0788A56B2

P356

Q33203569-FEC6019A-8A98-40CB-96E1-7364520B3D00

P433

Q33203569-687A38F0-277C-482D-9A1A-36DA0D37404E

P478

Q33203569-63EB83FF-CCBC-465E-AF87-91C7893C8E5D

P50

Q33203569-B6DCD185-6567-44DB-BA58-87A10111CDE4

P577

Q33203569-12329B6B-2C50-4E74-A422-5F50BC438AB9

P5875

Q33203569-E513149F-FBA4-44CF-AB67-0C994AB7CA11

P698

Q33203569-192BF3E1-369B-49BC-AA4F-F74B34105BEE

P921

Q33203569-DDBCA429-4F32-4E91-B209-93592A24CA6B

P356

P1433

International Journal of Cancer

P1476

Hypoxia-inducible factor-1 alp ...... otease and apoptosis pathways.

@en

P2093

Daniel E B Swinson

http://www.w3.org/2001/XMLSchema#string

Donna Richardson

http://www.w3.org/2001/XMLSchema#string

Giles Cox

http://www.w3.org/2001/XMLSchema#string

J Louise Jones

http://www.w3.org/2001/XMLSchema#string

Kenneth J O'Byrne

http://www.w3.org/2001/XMLSchema#string

P2860

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

The histological structure of some human lung cancers and the possible implications for radiotherapy.

Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated prot

P304

43-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.20052

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Adrian L Harris

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8522424

http://www.w3.org/2001/XMLSchema#string

P698

15185341

http://www.w3.org/2001/XMLSchema#string

P921